Associate Professor Vivek Naranbhai is a leading immunulogist and medical oncologist and clinician-scientist who has been recruited to Monash University (School of Translational Medicine, Dept of Medicine) from Massachusetts General Hospital and Harvard Medical School, Boston, USA. He undertook his medical training at the Nelson R Mandela School of Medicine, Durban, South Africa concurrently completing a PhD in Virology and was appointed Deputy-director of the Vaccine and Pathogenesis Programme at CAPRISA in Durban before moving to Oxford University as a Rhodes Scholar to complete a DPhil in immunogenomics (2011-2015) and post-doctoral fellowships in Oxford and then at The Ragon Institute of MGH, MIT and Harvard & National Cancer Institute (NCI/NIH), USA. He then undertook further clinical training undertaking a residency at Massachusetts General Hospital and Fellowship in Haematology/Oncology at the Dana-Farber Cancer Institute and Massachusetts General Hospital, before being appointed as an Instructor in Medicine and Attending Physician (Haematology-Oncology) at Massachusetts General Hospital and Harvard Medical School.

A/Prof Naranbhai is the Lab head of the Laboratory of Translational Immunology: The Laboratory of Translational Immunology is focused on optimising antigen delivery and recognition to develop new medicines against infectious diseases and cancers.